Join SMi's 20th annual European Pharmaceutical Pricing and Reimbursement to hear exclusive case studies on the latest HTA regulation developments and other challenges associated to different geographical areas - including the Nordic region, Germany, Turkey, France, Japan, Netherlands and more. Our expert speaking faculty; made up from key industry personnel from big pharma, biotech and academia will thoroughly explain and offer advice on P&R and market access - including The Health Access Agency, GlaxoSmithKline, Ministry of Health (Germany), Mundipharma, National Pharmacy Association, Ipsen, Gilead, Ethical Medicines Industry Group and more...
Register online with the following code and receive a £300 discount: SMI7D6Z
Register online with the following code and receive a £300 discount: SMI7D6Z
